KUROS N
35.5
CHF
(-0.84%)
04/22/2025 - 15:34
Closed 15 min delayed data - Switzerland SWX Stocks
| Open: | 35.5 |
| Change: | -0.3 |
| Volume: | 333 |
| Low: | 35.5 |
| High: | 36.5 |
| High / Low range: | 1.0 |
| Type: | Stocks |
| Ticker: | KURN |
| ISIN: | CH0325814116 |
KUROS N news, videos and press releases
For more news please use our advanced search feature.
KUROS N - More news...
KUROS N - More news...
- 04/15/2025 - 12:01 Annual General Meeting of Kuros Biosciences approves all resolutions
- 04/15/2025 - 05:00 Kuros Biosciences reports 82% year over year increase in sales in the first three months of 2025
- 03/11/2025 - 06:00 Kuros Biosciences grows sales to CHF 75.6 million for 2024
- 01/07/2025 - 06:00 Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the Medtronic spinal division
- 01/07/2025 - 01:20 Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
- 11/19/2024 - 06:00 Kuros Biosciences Expands into Extremities Markets
- 11/19/2024 - 01:20 Kuros Biosciences Expands into Extremities Markets
- 10/10/2024 - 05:00 Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow breakeven in the first nine months of 2024
- 10/10/2024 - 01:20 Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024
- 08/08/2024 - 05:00 Kuros Biosciences Reports First Half of 2024 Results
- 08/08/2024 - 01:30 Kuros Biosciences Reports First Half of 2024 Results
- 06/25/2024 - 05:00 Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
- 06/25/2024 - 01:20 Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft
- 04/24/2024 - 05:00 Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
- 04/24/2024 - 01:20 Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales
- 04/17/2024 - 12:05 Annual General Meeting of Kuros Biosciences approves all resolutions
- 04/17/2024 - 08:30 Annual General Meeting of Kuros Biosciences Approves All Resolutions
- 03/13/2024 - 06:00 Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
- 03/13/2024 - 02:20 Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023
- 03/08/2024 - 06:00 Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
- 03/08/2024 - 01:20 Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
- 02/01/2024 - 06:00 Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
- 02/01/2024 - 01:20 Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
- 01/31/2024 - 06:00 Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
- 01/31/2024 - 01:38 Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
- 01/04/2024 - 06:00 Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA
- 01/04/2024 - 01:20 Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA
- 12/27/2023 - 06:00 Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
- 12/27/2023 - 01:20 Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
- 11/28/2023 - 17:00 Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
